154 related articles for article (PubMed ID: 8011194)
1. Prolactinomas in men masquerading as invasive skull base tumours.
Cook RJ; Uttley D; Wilkins PR; Archer DJ; Bell BA
Br J Neurosurg; 1994; 8(1):51-5. PubMed ID: 8011194
[TBL] [Abstract][Full Text] [Related]
2. Clinical and histological correlations in prolactinomas, with special reference to bromocriptine resistance.
Delgrange E; Sassolas G; Perrin G; Jan M; Trouillas J
Acta Neurochir (Wien); 2005 Jul; 147(7):751-7; discussion 757-8. PubMed ID: 15971099
[TBL] [Abstract][Full Text] [Related]
3. Prolactin secreting pituitary carcinoma.
Petterson T; MacFarlane IA; MacKenzie JM; Shaw MD
J Neurol Neurosurg Psychiatry; 1992 Dec; 55(12):1205-6. PubMed ID: 1479402
[TBL] [Abstract][Full Text] [Related]
4. Spherical amyloid deposition in prolactinoma.
Gupta M; Grover N; Sen R
Indian J Pathol Microbiol; 2020; 63(3):491-492. PubMed ID: 32769350
[No Abstract] [Full Text] [Related]
5. Growth of prolactinoma despite lowering of serum prolactin by bromocriptine.
Kupersmith MJ; Kleinberg D; Warren FA; Budzilovitch G; Cooper P
Neurosurgery; 1989 Mar; 24(3):417-23. PubMed ID: 2927618
[TBL] [Abstract][Full Text] [Related]
6. [Prolactinoma in a child showing high MIB-1 labeling index: a case report].
Akamine S; Miyamoto T; Sugiura Y; Takehara S; Hiramatsu H; Nishizawa S; Yokota N
No Shinkei Geka; 2000 Jun; 28(6):547-53. PubMed ID: 10875113
[TBL] [Abstract][Full Text] [Related]
7. Malignant growth of a recurrent macroprolactinoma after radiation therapy.
Rainov NG; Burkert W
Neurochirurgia (Stuttg); 1993 Sep; 36(5):172-5. PubMed ID: 8272171
[TBL] [Abstract][Full Text] [Related]
8. Combined treatment of invasive giant prolactinomas.
Yu C; Wu Z; Gong J
Pituitary; 2005; 8(1):61-5. PubMed ID: 16411070
[TBL] [Abstract][Full Text] [Related]
9. Prolactin secreting pituitary adenomas: analysis of 429 surgically treated patients, effect of adjuvant treatment modalities and review of the literature.
Ozgen T; Oruckaptan HH; Ozcan OE; Acikgoz B
Acta Neurochir (Wien); 1999; 141(12):1287-94. PubMed ID: 10672299
[TBL] [Abstract][Full Text] [Related]
10. [Prolactin producing hypophyseal carcinoma. Case report of an extremely rare metastatic tumor].
Saeger W; Bosse U; Pfingst E; Schierke G; Kulinna H; Atkins D; Gullotta F
Pathologe; 1995 Sep; 16(5):354-8. PubMed ID: 7479609
[TBL] [Abstract][Full Text] [Related]
11. Magnetic resonance imaging measurements of pituitary stalk compression and deviation in patients with nonprolactin-secreting intrasellar and parasellar tumors: lack of correlation with serum prolactin levels.
Smith MV; Laws ER
Neurosurgery; 1994 May; 34(5):834-9; discussion 839. PubMed ID: 8052379
[TBL] [Abstract][Full Text] [Related]
12. Surgery, dopamine agonist therapy of combined treatment--results in prolactinoma patients after a 12 month follow-up.
Hildebrandt G; Bauer T; Stracke H; Fassbender WJ; Mueller HW; Agnoli AL; Federlin K; Roosen K
Zentralbl Neurochir; 1992; 53(3):123-34. PubMed ID: 1414079
[TBL] [Abstract][Full Text] [Related]
13. Spontaneous shrinking of a macroprolactinoma.
Rainov NG; Burkert W
Neurochirurgia (Stuttg); 1993 Jan; 36(1):17-9. PubMed ID: 8446291
[TBL] [Abstract][Full Text] [Related]
14. Giant invasive prolactinomas.
Murphy FY; Vesely DL; Jordan RM; Flanigan S; Kohler PO
Am J Med; 1987 Nov; 83(5):995-1002. PubMed ID: 3674103
[TBL] [Abstract][Full Text] [Related]
15. Aggressive pituitary macroadenoma: CT and MR appearances.
Van de Straete S; Githeko J; Demaerel P; Wilms G; Lammens M; Plets C; Bouillon R; Baert AL
J Belge Radiol; 1996 Dec; 79(6):255-7. PubMed ID: 9031535
[TBL] [Abstract][Full Text] [Related]
16. Suprasellar ectopic pituitary adenoma.
Nagatani T; Shibuya M; Suzuki Y; Saito K; Yoshida J
Acta Neurochir (Wien); 1997; 139(1):94-5. PubMed ID: 9059722
[No Abstract] [Full Text] [Related]
17. [Morphological changes in prolactinoma induced by bromocriptine treatment].
Scanarini M
Minerva Endocrinol; 1990; 15(1):13-5. PubMed ID: 2274009
[TBL] [Abstract][Full Text] [Related]
18. Giant prolactinomas: clinical management and long-term follow up.
Shrivastava RK; Arginteanu MS; King WA; Post KD
J Neurosurg; 2002 Aug; 97(2):299-306. PubMed ID: 12186457
[TBL] [Abstract][Full Text] [Related]
19. [Clinical aspects, morphology and biology of prolactinomas after therapy with dopamine agonists. A review of the literature].
Kobras G
Pathologe; 1992 Jul; 13(4):183-9. PubMed ID: 1508856
[No Abstract] [Full Text] [Related]
20. "Hook effect" in prolactinomas: case report and review of literature.
Frieze TW; Mong DP; Koops MK
Endocr Pract; 2002; 8(4):296-303. PubMed ID: 12173917
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
